Errors in Figure 2 and eTable 3 in the Supplement

In the Original Investigation titled “Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes,”¹ published June 28, 2021, and in August print, there were numeric errors in Figure 2 in the main article and eTable 3 in the online Supplement. In both places, the values for cardiovascular analyses for “Yes” given as “−3.59 (−6.14 to −0.89)” and “0.85 (0.75-0.97)” should have been “−9.22 (−13.50 to −6.16)” and “0.75 (0.67-0.84).” The values for cardiovascular analyses for “No” given as “−4.95 (−6.90 to −3.31)” and “0.81 (0.75-0.88)” should have been “−3.23 (−5.25 to −1.29)” and “0.85 (0.76 to 0.94).” This article has been corrected online.